34.50GBp+2.37%Mkt Cap: 27.17M $P/E: —1d ago
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmenta…
Indicators:|
Key Statistics
Company
Market Cap27.17M $
Enterprise Value16.90M $
Revenue (TTM)21.77M $
Gross Profit13.71M $
Net Income (TTM)-24.87M $
Revenue/Share0.3087 USD
Last Price34.50 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees216
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.05
PEG—
EV/EBITDA6.00
EV/Revenue0.78
P/S1.25
P/B1.04
EPS (TTM)-0.33
EPS (Forward)-6.96
52W Range
26.6013% of range86.00
52W High86.00 GBp
52W Low26.60 GBp
Profitability
Gross Margin62.98%
Oper. Margin-59.36%
EBITDA Margin12.95%
Profit Margin-114.25%
ROE-97.91%
ROA-56.74%
Growth
Revenue Growth6.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.79M $
CapEx (TTM)957.61K $
FCF Margin36.82%
FCF Yield29.51%
Net Debt-9.58M $
Net Debt/EBITDA-3.40
Balance Sheet
Debt/Equity0.45
Current Ratio4.75
Quick Ratio4.16
Book Value/Sh0.3310 GBp
Cash/Share0.2730 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6600.00 GBp
Upside (mean)+19030.4%
Target Range6600.00 GBp – 6600.00 GBp
# Analysts1
Ownership
Shares Out.72.44M
Float70.41M
Insiders0.06%
Institutions0.00%
Technical
SMA 5040.48 (-14.8%)
SMA 20037.51 (-8.0%)
Beta1.10
S&P 52W Chg20.05%
Avg Vol (30d)279.44K
Avg Vol (10d)197.41K
Technical Indicators
RSI (14)43.4
MACD-2.3764
MACD Signal-2.2579
MACD Hist.-0.1185
BB Upper41.60 GBp
BB Middle36.31 GBp
BB Lower31.03 GBp
BB Width29.09%
ATR (14)4.175 GBp
Vol Ratio (20d)0.42x